SCHEMBL6207629

SCHEMBL6207629

NC(=O)CN1CCCCC1C(O)(c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
TACR1 P25103 2/20 0.43
CHRM3 P20309 6/20 0.41
CHRM2 P08172 5/20 0.41
CHRM1 P11229 5/20 0.41
HTT P42858 1/20 0.41
RECQL P46063 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ALDH1A1 P00352 1/20 0.41
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
DUT P33316 2/20 0.40
CYP2D6 P10635 3/20 0.39
KCNH2 Q12809 2/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
HRH1 P35367 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10123845 0.83 LMNA (0.51) LMNACHRM3CHRM2CHRM1ALDH1A1
SCHEMBL8336623 0.79 LMNA (0.56) LMNACHRM3CHRM2CHRM1DUT
SCHEMBL8336619 0.79 LMNA (0.56) LMNACHRM3CHRM2CHRM1DUT
SCHEMBL8339280 0.79 LMNA (0.56) LMNACHRM3CHRM2CHRM1DUT
SCHEMBL6688937 0.78 KDM4E (0.40) LMNATACR1CHRM3CHRM2CHRM1
SCHEMBL6264165 0.76 LMNA (0.44) LMNACHRM3CHRM2CHRM1DUT
SCHEMBL7493746 0.76 KDM4E (0.55) TACR1ALDH1A1TDP1OPRM1SIGMAR1
SCHEMBL8735443 0.75 LMNA (0.44) LMNACHRM3CHRM2CHRM1HTT
SCHEMBL5266516 0.74 LMNA (0.70) LMNACHRM3CHRM2CHRM1HTT
SCHEMBL20128479 0.74 LMNA (0.51) LMNAALDH1A1KCNH2HRH1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-A4 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2005-03-30 EP disclosed
EP-1465631-A2 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI Pharmaceuticals, Inc. (US) 2004-10-13 EP disclosed
WO-2003053366-A2 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARMACEUTICALS, INC. (US) 2003-07-03 WO disclosed